RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.998
EU - Europa 6.018
AS - Asia 5.195
SA - Sud America 625
Continente sconosciuto - Info sul continente non disponibili 230
AF - Africa 114
OC - Oceania 4
Totale 25.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.779
GB - Regno Unito 1.839
SG - Singapore 1.390
IT - Italia 1.333
CN - Cina 1.320
HK - Hong Kong 763
SE - Svezia 629
VN - Vietnam 567
BR - Brasile 459
DE - Germania 434
FI - Finlandia 345
BD - Bangladesh 323
NL - Olanda 319
RU - Federazione Russa 271
FR - Francia 243
UA - Ucraina 233
TR - Turchia 198
IN - India 135
CA - Canada 113
KR - Corea 106
BG - Bulgaria 94
ID - Indonesia 71
MX - Messico 53
AR - Argentina 51
IQ - Iraq 45
BE - Belgio 40
JP - Giappone 38
CZ - Repubblica Ceca 31
PL - Polonia 30
ZA - Sudafrica 30
ES - Italia 28
IE - Irlanda 24
UZ - Uzbekistan 24
AE - Emirati Arabi Uniti 23
IR - Iran 23
PK - Pakistan 23
AT - Austria 22
CL - Cile 21
CO - Colombia 21
EC - Ecuador 21
LT - Lituania 20
MA - Marocco 20
VE - Venezuela 18
MY - Malesia 17
KE - Kenya 16
BZ - Belize 15
PH - Filippine 15
AZ - Azerbaigian 14
PY - Paraguay 14
EG - Egitto 13
EU - Europa 11
JM - Giamaica 11
TN - Tunisia 11
RO - Romania 10
SA - Arabia Saudita 10
CY - Cipro 9
DK - Danimarca 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
CH - Svizzera 8
NP - Nepal 8
RS - Serbia 8
CR - Costa Rica 7
DZ - Algeria 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
PS - Palestinian Territory 7
TH - Thailandia 7
AL - Albania 6
BO - Bolivia 6
BY - Bielorussia 6
GR - Grecia 6
OM - Oman 6
UY - Uruguay 6
KG - Kirghizistan 5
EE - Estonia 4
ET - Etiopia 4
AM - Armenia 3
AU - Australia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 24.943
Salva come PNG Salva come JPEG
Città #
Ashburn 1.362
Southend 1.357
Fairfield 1.240
Santa Clara 1.050
Singapore 883
Woodbridge 804
Hong Kong 750
Chandler 637
Houston 588
San Jose 529
Ann Arbor 507
Seattle 478
Jacksonville 428
Wilmington 424
Dearborn 423
Cambridge 390
Nyköping 350
Hefei 331
Council Bluffs 303
Beijing 294
Amsterdam 248
Helsinki 241
New York 236
London 230
Modena 204
Los Angeles 197
Ho Chi Minh City 186
Chicago 168
Milan 128
The Dalles 127
Hanoi 126
Izmir 105
San Diego 104
Seoul 102
Munich 93
Sofia 90
Buffalo 87
Princeton 87
Eugene 82
Fremont 75
Moscow 73
Lauterbourg 71
Rome 67
Columbus 58
Dallas 56
Bremen 55
Shanghai 52
Orem 48
Jakarta 46
Des Moines 41
Salt Lake City 41
Boardman 40
Bologna 40
São Paulo 40
Frankfurt am Main 36
Brussels 33
Tokyo 32
Redwood City 31
Da Nang 29
Ottawa 28
Atlanta 27
Boston 26
Montreal 24
Naples 24
Toronto 24
Turku 24
Chennai 23
Paris 23
Haiphong 22
Tashkent 22
Warsaw 22
Washington 22
San Francisco 21
Dublin 20
Tampa 20
Elk Grove Village 19
Las Vegas 19
Philadelphia 19
Brooklyn 18
Denver 17
Mexico City 17
Guangzhou 16
Johannesburg 16
Phoenix 16
Rio de Janeiro 16
Stockholm 16
Belize City 15
Miano 15
Nairobi 15
Palermo 15
Reggio Emilia 15
Albuquerque 14
Detroit 14
Kunming 14
Baghdad 13
Manchester 13
Mumbai 13
Nanjing 13
Vienna 13
Chiswick 12
Totale 17.688
Salva come PNG Salva come JPEG
Nome #
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 448
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 445
B cells and herpesviruses: a model of lymphoproliferation 434
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 426
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 414
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 388
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 387
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 387
Mucorales-specific T cells in patients with hematologic malignancies 378
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 377
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 369
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 369
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 366
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 364
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 364
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 363
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 357
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 356
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 353
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 352
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 350
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 346
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 344
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 330
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 328
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 323
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 319
Parvoviruses in blood donors and transplant patients, Italy 318
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 317
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 312
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 310
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 307
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 303
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 298
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 295
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 294
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 292
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 291
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 289
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 286
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 285
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 285
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 284
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 283
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 281
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 274
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 271
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 271
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 271
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 268
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 265
How I treat HHV8/KSHV-related diseases in posttransplant patients. 262
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 257
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 256
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 255
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 252
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 251
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 249
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 243
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 243
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 241
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 233
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 229
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 224
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 220
Pneumonia in acute leukaemia:blossoming culprits 218
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 214
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 208
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 206
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 203
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 196
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 195
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 193
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 190
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 183
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 183
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 182
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 180
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 179
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 160
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 160
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 151
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 149
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 145
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 133
The dynamic functions of IRF4 in B cell malignancies 113
Totale 25.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.680 0 228 221 98 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20253.847 155 49 76 279 701 541 309 231 431 151 385 539
2025/20267.199 611 367 609 647 969 498 882 332 726 620 540 398
2026/2027631 180 451 0 0 0 0 0 0 0 0 0 0
Totale 25.184